About Aurinia (AUPH)
Aurinia Pharmaceuticals Inc. is a Canada-based clinical-stage biopharmaceutical company operating in the field of nephrology and autoimmunity. The Company's primary business is the development of a therapeutic drug to treat autoimmune diseases, in pa... Read more
- USD8.29
- USD9.10
- USD8.28
- USD10.67
- 3.10%
- 240M
- 5.35M
- 1.49M
- 1.0B
- 5.20
- 52.00%
- 14.30%
Stock News
yesterday
Levi's CEO Michelle Gass says strong international business helps ward off tariff impact
CNBC
yesterday
Nvidia officially gets its $4 trillion finish. Here’s what could come next.
MarketWatch
yesterday
Levi Strauss raises sales guidance, says it will absorb some tariff costs for now
CNBC
yesterday
Business class+? Delta says segmentation is coming to high-end cabins
CNBC
Unlock More Stock Analysis & Reports
Access detailed stock analysis from LSEG including analyst price target estimates.
